The Firm represented New Mountain Capital in connection with its majority investment in Covaris. Financial terms of the transaction were not disclosed.~~Covaris develops, manufactures and markets instruments, consumables and reagents used in pre-analytical sample preparation for genomic and proteomic analysis to help accelerate the pace of research and life science innovations. Some of the non-contact applications include faster automated DNA fragmentation, cell lysis, accelerated binding partner mixing, bead resuspension and compound formulation.~~The Simpson Thacher team included Elizabeth Cooper, Matthew Rogers and Christopher Scavone (M&A); Vanessa Burrows and Tera Rule (Healthcare Regulatory); Christopher Brown, Benjamin Persina, Noah DeBlasi, Mark Haddox, Cem Islikci and Daniel Levine (Credit); Andrew Purcell, Dmitry Zelik and Adam Hersch (Tax); Andrew Blau, Ryan Stott and Hannah Daniels (Executive Compensation & Employee Benefits); Lori Lesser, Alysha Sekhon and Samuel Watters (IP); and Adeeb Fadil and Noreen Lavan (Environmental).